Sep 2026
CD3-engaging bispecific antibodies convert human regulatory T cells into cytotoxic effectors
J. Michel, J. Frenking, A. Metzler et al.
· medRxiv · 0 citations
AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
We have 2 of 5 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
TFiT (tumor-reactive features in T cells), a transcriptional classifier that identifies tumor-reactive T cells and stratifies immunotherapy, but not chemotherapy, response across independent MM and AML cohorts, supporting its specificity for T cell-mediated tumor control.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.